Test angiogenic tests and ultrasound for slow fetal growth
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study looks at how early, slow fetal growth is managed during pregnancy. It compares an “angiogenic factors” approach with an ultrasound (blood-flow) approach to help guide care and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and pregnant
- Your pregnancy is a single baby (not twins or more)
- At 26 to 31+6 weeks, the estimated baby weight is at or below the 10th percentile
- Your pregnancy dates are confirmed by a first-trimester scan (11 to 13+6 weeks) or by IVF dates
- The baby does not have major birth defects or a known genetic disorder
- You are able to give informed consent (you do not need to withdraw consent)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether measuring two pregnancy blood markers (sFlt1 and PlGF) and planning delivery timing can help prevent preeclampsia as you reach term. It may help reduce risk for mother and baby by guiding when to deliver based on test results.
This study tests whether measuring certain proteins in the blood (angiogenic factors) can help doctors better manage preeclampsia in women who are 36 to 38 weeks pregnant. The goal is to see if this approach can safely delay delivery and improve outcomes for both mother and baby.
This study looks at therapies meant to support brain development in babies whose growth is slower than expected before birth. It enrolls pregnancies in a specific time window and uses ultrasound/Doppler testing to make sure the baby is not likely needing delivery immediately.
This study tests whether a blood-thinner medicine (LMWH) can improve outcomes for people carrying a singleton baby with early signs of slow growth. It compares LMWH against standard care to see if treatment helps the baby and pregnancy stay safer.
This study uses special imaging techniques to look at the placenta during pregnancy. It aims to learn more about normal pregnancies and those where the baby is growing more slowly than expected.
This study looks at babies in monochorionic (shared-placenta) twin pregnancies where one or both babies are growing too slowly. It aims to better understand this condition and follow families over time to improve care, with check-ins through age 2 after birth.
Hear when a new Fetal Growth Retardation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.